Global Assisted Reproductive Technologies Medications Industry

2024-2029 Global Assisted Reproductive Technologies Medications Industry Research & Trends Analysis Report

Global Assisted Reproductive Technologies Medications Industry

2024-2029 Global Assisted Reproductive Technologies Medications Industry Research & Trends Analysis Report


Get latest Market Research Reports on Assisted Reproductive Technologies Medications. Industry analysis and Market Report on Assisted Reproductive Technologies Medications is a syndicated market report, published as Global Assisted Reproductive Technologies Medications Market Research Report . It is complete Research Study and Industry Analysis of Assisted Reproductive Technologies Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Assisted reproductive technology (ART) is used to treat infertility. It includes fertility treatments that handle both eggs and sperm. A number of different agents are used to achieve controlled ovarian hyperstimulation. These include clomiphene, GnRH analogues, menotropins, urofollitropin, highly purified FSH, and recombinant human FSH (rh-FSH), etc.

This report aims to provide a comprehensive study of the global market for Assisted Reproductive Technologies Medications. Report Highlights:

(1) Global Assisted Reproductive Technologies Medications market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Assisted Reproductive Technologies Medications market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Assisted Reproductive Technologies Medications market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Assisted Reproductive Technologies Medications segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Assisted Reproductive Technologies Medications segment by type and by application and regional segment by type and by application.

(6) Assisted Reproductive Technologies Medications industry supply chain, upstream, midstream and downstream analysis.

According to latest study, the global market for Assisted Reproductive Technologies Medications should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Assisted Reproductive Technologies Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Assisted Reproductive Technologies Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Down-Regulation Drugs segment holds a share about % in 2022 and will reach % in 2029; while in terms of channel, Hospital Pharmacy has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Assisted Reproductive Technologies Medications include Merck, MSD, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju and Changchun GeneScience, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Down-Regulation Drugs

Ovulation Stimulation Drugs

Ovulation Inducing Drugs

Luteal Support Medications

Market segment by channel, can be divided into

Hospital Pharmacy

Specialty & Retail Pharmacy

Online Pharmacy

Market segment by players, this report covers

Merck

MSD

Ipsen

Ferring

Organon

Solvay

Besins

Zhejiang Xianju

Changchun GeneScience

Hybio Pharmaceutical

Livzon Pharmaceutical

1 Market Overview

1.1 Product Overview and Scope of Assisted Reproductive Technologies Medications

1.2 Global Assisted Reproductive Technologies Medications Market Size and Forecast

1.3 China Assisted Reproductive Technologies Medications Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Assisted Reproductive Technologies Medications Share in Global Market, 2018-2029

1.4.2 Assisted Reproductive Technologies Medications Market Size: China VS Global, 2018-2029

1.5 Assisted Reproductive Technologies Medications Market Dynamics

1.5.1 Assisted Reproductive Technologies Medications Market Drivers

1.5.2 Assisted Reproductive Technologies Medications Market Restraints

1.5.3 Assisted Reproductive Technologies Medications Industry Trends

1.5.4 Assisted Reproductive Technologies Medications Industry Policy

2 Global Competitive Situation by Company

2.1 Global Assisted Reproductive Technologies Medications Revenue by Company (2018-2023)

2.2 Global Assisted Reproductive Technologies Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Assisted Reproductive Technologies Medications Concentration Ratio

2.4 Global Assisted Reproductive Technologies Medications Mergers & Acquisitions, Expansion Plans

2.5 Global Assisted Reproductive Technologies Medications Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Assisted Reproductive Technologies Medications Revenue by Company (2018-2023)

3.2 China Assisted Reproductive Technologies Medications Assisted Reproductive Technologies Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Assisted Reproductive Technologies Medications, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Assisted Reproductive Technologies Medications Industry Chain

4.2 Assisted Reproductive Technologies Medications Upstream Analysis

4.3 Assisted Reproductive Technologies Medications Midstream Analysis

4.4 Assisted Reproductive Technologies Medications Downstream Analysis

5 Sights by Type

5.1 Assisted Reproductive Technologies Medications Classification

5.1.1 Down-Regulation Drugs

5.1.2 Ovulation Stimulation Drugs

5.1.3 Ovulation Inducing Drugs

5.1.4 Luteal Support Medications

5.2 By Type, Global Assisted Reproductive Technologies Medications Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Assisted Reproductive Technologies Medications Revenue, 2018-2029

6 Sights by Channel

6.1 Assisted Reproductive Technologies Medications Segment by Channel

6.1.1 Hospital Pharmacy

6.1.2 Specialty & Retail Pharmacy

6.1.3 Online Pharmacy

6.2 By Application, Global Assisted Reproductive Technologies Medications Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Assisted Reproductive Technologies Medications Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Assisted Reproductive Technologies Medications Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Assisted Reproductive Technologies Medications Market Size, 2018-2029

7.3 North America

7.3.1 North America Assisted Reproductive Technologies Medications Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Assisted Reproductive Technologies Medications Market Size Market Share

7.4 Europe

7.4.1 Europe Assisted Reproductive Technologies Medications Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Assisted Reproductive Technologies Medications Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Assisted Reproductive Technologies Medications Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Assisted Reproductive Technologies Medications Market Size Market Share

7.6 South America

7.6.1 South America Assisted Reproductive Technologies Medications Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Assisted Reproductive Technologies Medications Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Assisted Reproductive Technologies Medications Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Assisted Reproductive Technologies Medications Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Assisted Reproductive Technologies Medications Market Size, 2018-2029

8.3.2 By Company, U.S. Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.3.4 By Channel, U.S. Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Assisted Reproductive Technologies Medications Market Size, 2018-2029

8.4.2 By Company, Europe Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.4.4 By Channel, Europe Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Assisted Reproductive Technologies Medications Market Size, 2018-2029

8.5.2 By Company, China Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2023

8.5.3 By Type, China Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.5.4 By Channel, China Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Assisted Reproductive Technologies Medications Market Size, 2018-2029

8.6.2 By Company, Japan Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.6.4 By Channel, Japan Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Assisted Reproductive Technologies Medications Market Size, 2018-2029

8.7.2 By Company, South Korea Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.7.4 By Channel, South Korea Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Assisted Reproductive Technologies Medications Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.8.4 By Channel, Southeast Asia Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Assisted Reproductive Technologies Medications Market Size, 2018-2029

8.9.2 By Company, India Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2023

8.9.3 By Type, India Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.9.4 By Channel, India Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Assisted Reproductive Technologies Medications Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Assisted Reproductive Technologies Medications Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

8.10.4 By Channel, Middle East & Asia Assisted Reproductive Technologies Medications Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Merck

9.1.1 Merck Company Information, Head Office, Market Area and Industry Position

9.1.2 Merck Company Profile and Main Business

9.1.3 Merck Assisted Reproductive Technologies Medications Models, Specifications and Application

9.1.4 Merck Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.1.5 Merck Recent Developments

9.2 MSD

9.2.1 MSD Company Information, Head Office, Market Area and Industry Position

9.2.2 MSD Company Profile and Main Business

9.2.3 MSD Assisted Reproductive Technologies Medications Models, Specifications and Application

9.2.4 MSD Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.2.5 MSD Recent Developments

9.3 Ipsen

9.3.1 Ipsen Company Information, Head Office, Market Area and Industry Position

9.3.2 Ipsen Company Profile and Main Business

9.3.3 Ipsen Assisted Reproductive Technologies Medications Models, Specifications and Application

9.3.4 Ipsen Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.3.5 Ipsen Recent Developments

9.4 Ferring

9.4.1 Ferring Company Information, Head Office, Market Area and Industry Position

9.4.2 Ferring Company Profile and Main Business

9.4.3 Ferring Assisted Reproductive Technologies Medications Models, Specifications and Application

9.4.4 Ferring Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.4.5 Ferring Recent Developments

9.5 Organon

9.5.1 Organon Company Information, Head Office, Market Area and Industry Position

9.5.2 Organon Company Profile and Main Business

9.5.3 Organon Assisted Reproductive Technologies Medications Models, Specifications and Application

9.5.4 Organon Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.5.5 Organon Recent Developments

9.6 Solvay

9.6.1 Solvay Company Information, Head Office, Market Area and Industry Position

9.6.2 Solvay Company Profile and Main Business

9.6.3 Solvay Assisted Reproductive Technologies Medications Models, Specifications and Application

9.6.4 Solvay Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.6.5 Solvay Recent Developments

9.7 Besins

9.7.1 Besins Company Information, Head Office, Market Area and Industry Position

9.7.2 Besins Company Profile and Main Business

9.7.3 Besins Assisted Reproductive Technologies Medications Models, Specifications and Application

9.7.4 Besins Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.7.5 Besins Recent Developments

9.8 Zhejiang Xianju

9.8.1 Zhejiang Xianju Company Information, Head Office, Market Area and Industry Position

9.8.2 Zhejiang Xianju Company Profile and Main Business

9.8.3 Zhejiang Xianju Assisted Reproductive Technologies Medications Models, Specifications and Application

9.8.4 Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.8.5 Zhejiang Xianju Recent Developments

9.9 Changchun GeneScience

9.9.1 Changchun GeneScience Company Information, Head Office, Market Area and Industry Position

9.9.2 Changchun GeneScience Company Profile and Main Business

9.9.3 Changchun GeneScience Assisted Reproductive Technologies Medications Models, Specifications and Application

9.9.4 Changchun GeneScience Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.9.5 Changchun GeneScience Recent Developments

9.10 Hybio Pharmaceutical

9.10.1 Hybio Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.10.2 Hybio Pharmaceutical Company Profile and Main Business

9.10.3 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Models, Specifications and Application

9.10.4 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.10.5 Hybio Pharmaceutical Recent Developments

9.11 Livzon Pharmaceutical

9.11.1 Livzon Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.11.2 Livzon Pharmaceutical Company Profile and Main Business

9.11.3 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Models, Specifications and Application

9.11.4 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue and Gross Margin, 2018-2023

9.11.5 Livzon Pharmaceutical Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Assisted Reproductive Technologies Medications Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Is the Assisted Reproductive Technologies Medications Market shifting its focus from growth to value?
Recognize the areas along the Assisted Reproductive Technologies Medications Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
What are the major applications for Assisted Reproductive Technologies Medications?
Assisted Reproductive Technologies Medications has a wide range of applications, including and others.
What is the estimated size & growth rate of the Assisted Reproductive Technologies Medications Market?
In recent years, the Assisted Reproductive Technologies Medications Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
Is further segmentation possible given the scope of the Assisted Reproductive Technologies Medications Market study?
Yes, the add-on segmentation is available in the premium customised version of the Assisted Reproductive Technologies Medications Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
What does the future hold for the Assisted Reproductive Technologies Medications Industry?
This latest research publication on the Assisted Reproductive Technologies Medications Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.